177 related articles for article (PubMed ID: 15004438)
1. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth.
Wolańska M; Sobolewski K; Bańkowski E; Jaworski S
Gynecol Obstet Invest; 2004; 58(1):14-8. PubMed ID: 15004438
[TBL] [Abstract][Full Text] [Related]
2. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in the vein wall.
Kowalewski R; Sobolewski K; Wolanska M; Gacko M
Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Palmer SS; Haynes-Johnson D; Diehl T; Nowak RA
J Soc Gynecol Investig; 1998; 5(4):203-9. PubMed ID: 9699179
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
10. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
Korompelis P; Piperi C; Adamopoulos C; Dalagiorgou G; Korkolopoulou P; Sepsa A; Antsaklis A; Papavassiliou AG
Clin Chem Lab Med; 2015 Aug; 53(9):1415-24. PubMed ID: 25470608
[TBL] [Abstract][Full Text] [Related]
15. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
Yang JH; Wu MY; Chen MJ; Chen SU; Yang YS; Ho HN
Fertil Steril; 2009 May; 91(5 Suppl):2193-8. PubMed ID: 18692810
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
18. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
[TBL] [Abstract][Full Text] [Related]
19. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
Morikawa A; Ohara N; Xu Q; Nakabayashi K; DeManno DA; Chwalisz K; Yoshida S; Maruo T
Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]